Tolerogenic Reverse Micelle Nanovaccine Prevents Onset and Progression of Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tolerogenic Reverse Micelle Nanovaccine Prevents Onset and Progression of Multiple Sclerosis

Published:2024-09-13 Issue: Volume: Page:
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Zhang Rui¹,Zhang Haolin¹,Wang Yue¹,Hu Yuxin¹,Ma Qing¹,Huang Weijia¹,Li Xin²,Wang Yongjun¹³^ORCID,Liu Hongzhuo¹³^ORCID

Affiliation:

1. Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, P. R. China

2. First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121002, Liaoning, P. R. China

3. Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, P. R. China

Funder

Shenyang Science and Technology Development Funds

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.4c03301

Reference39 articles.

1. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting

2. Multiple Sclerosis: Mechanisms and Immunotherapy

3. The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies

4. Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic

5. Tolerogenic Nanovaccine for Prevention and Treatment of Autoimmune Encephalomyelitis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP